Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Pure Extracts Technologies Corp. (CSE: PULL) Issues Corporate Update Detailing Operations, Product Strategy and Market Conditions

Pure Extracts is a plant-based extraction company located in British Columbia, Canada that focuses on cannabis, hemp, functional mushrooms Pure Extracts’ “Pure Pulls” and “Pure Mushrooms’” branded products expected to be available by end of Q1 2021 Global cannabis extract market size expected to reach USD$28.5 billion by 2027 with CAGR of 16.6%; global functional […]

Friendable Inc. (FDBL) Fan Pass Platform Signs Remy Boy Monty

FDBL announces new artist acquisition: Remy Boy Monty Fan Pass capable of satisfying fans’ overwhelming appetite for content while providing new revenue streams for Monty Monty opens up potential for signing additional artists With the focus of connecting and engaging users, the mobile tech and marketing company Friendable (OTC: FDBL) launched its platform Fan Pass […]

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Leverages Key Strengths Essential in Today’s Mining Sector

David Elliott, industry veteran and member of Canadian Mining Hall of Fame, cites right people, right science as key factors to mining success Elliott finds certain jurisdictions, including Canada and South America, compelling mining locations Led by industry-seasoned professionals and operating in Canada and Chile, GoldHaven Resources appears well positioned to respond to mining investors’ […]

CNS Pharmaceuticals (NASDAQ: CNSP) Advances Brain Cancer Drug Candidate and Sponsors Annual SNO Conference

Biotechnology developer CNS Pharmaceuticals is preparing, with its partner WPD Pharmaceuticals, a global set of Phase 2 trials for its drug candidate Berubicin, which has shown promise in combating the effectively fatal glioblastoma multiforme (“GBM”) brain cancer Since another company conducted Phase 1 safety trials for Berubicin 14 years ago, one patient has survived cancer-free […]

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Releases Q3 Financial Results, Corporate Highlights

Financial report notes working capital of $44.7 million at end of Q3 2020, increase of 17% over Q2 2020 Key quarter highlights include becoming debt-free, progress on rare earth elements (“REEs”) CEO reports company making “significant strides in the last quarter on our uranium, rare earths and other initiatives” Energy Fuels (NYSE American: UUUU) (TSX: EFR) has […]

Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Focused on Readily Developable Copper-Gold Project as Demand Rises

Demand for copper is rising; deficit forecast in coming years Copper deficit heightens need for projects that can produce the high-demand metal Feasibility study concluded that Josemaria’s average annual metal production of 136,000 tonnes of copper (“Cu”), 231,000 ounces of gold (“AU”), 1,164, 000 ounces of silver (“Ag”) Strategic plan demonstrates commercial production at project […]

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment

VTGN CEO “even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such as sedation, cognitive impairment or abuse liability Company making significant progress in preparing PH94B for launch of pivotal Phase 3 […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

June 26, 2026

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk […]

Rotate your device 90° to view site.